BioCryst Pharmaceuticals
BCRX
#4949
Rank
โ‚น175.50 B
Marketcap
โ‚น682.11
Share price
-2.67%
Change (1 day)
10.04%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - P/B ratio

P/B ratio as of November 2026 : -4.13

According to BioCryst Pharmaceuticals 's latest financial reports the company has a price-to-book ratio of 1.95347.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

BioCryst Pharmaceuticals - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-31-13.3295.32%
2024-12-31-3.3624.59%
2023-12-31-2.69-62.93%
2022-12-31-7.26-68.81%
2021-12-31-23.3-65.89%
2020-12-31-68.3-591.41%
2019-12-3113.9-22.97%
2018-12-3118.0212.76%
2017-12-315.77-98.05%
2016-12-312961765.24%
2015-12-3115.937.12%
2014-12-3111.6-102.9%
2013-12-31-399150.56%
2012-12-31-159-2210.4%
2011-12-317.54112.56%
2010-12-313.557.92%
2009-12-313.29191.24%
2008-12-311.13-68.77%
2007-12-313.62-77.38%
2006-12-3116.093.53%
2005-12-318.2692.63%
2004-12-314.29-0.37%
2003-12-314.30918.74%
2002-12-310.4224

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Gilead Sciences
GILD
17.8-531.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
4.00-196.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
1.02-124.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
5.23-226.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-6.89 66.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
3.03-173.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
3.50-184.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
2.22-153.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.8283-120.03%๐Ÿ‡บ๐Ÿ‡ธ USA